Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mineralocorticoid Receptor and Sleep Quality in Chronic Kidney Disease.
de la Puente-Aldea J, Lopez-Llanos O, Horrillo D, Marcos-Sanchez H, Sanz-Ballesteros S, Franco R, Jaisser F, Senovilla L, Palacios-Ramirez R. de la Puente-Aldea J, et al. Among authors: jaisser f. Int J Mol Sci. 2024 Nov 16;25(22):12320. doi: 10.3390/ijms252212320. Int J Mol Sci. 2024. PMID: 39596384 Free PMC article. Review.
Mineralocorticoid Receptor Antagonism Prevents the Synergistic Effect of Metabolic Challenge and Chronic Kidney Disease on Renal Fibrosis and Inflammation in Mice.
Palacios-Ramirez R, Lima-Posada I, Bonnard B, Genty M, Fernandez-Celis A, Hartleib-Geschwindner J, Foufelle F, Lopez-Andres N, Bamberg K, Jaisser F. Palacios-Ramirez R, et al. Among authors: jaisser f. Front Physiol. 2022 Apr 7;13:859812. doi: 10.3389/fphys.2022.859812. eCollection 2022. Front Physiol. 2022. PMID: 35464084 Free PMC article.
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease.
Lima Posada I, Soulié M, Stephan Y, Palacios Ramirez R, Bonnard B, Nicol L, Pitt B, Kolkhof P, Mulder P, Jaisser F. Lima Posada I, et al. Among authors: jaisser f. J Am Heart Assoc. 2024 Jun 18;13(12):e032971. doi: 10.1161/JAHA.123.032971. Epub 2024 Jun 6. J Am Heart Assoc. 2024. PMID: 38842271 Free PMC article.
Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathway.
Palacios-Ramirez R, Soulié M, Fernandez-Celis A, Nakamura T, Boujardine N, Bonnard B, Bamberg K, Lopez-Andres N, Jaisser F. Palacios-Ramirez R, et al. Among authors: jaisser f. Clin Sci (Lond). 2024 Aug 21;138(16):1025-1038. doi: 10.1042/CS20240302. Clin Sci (Lond). 2024. PMID: 39092535
205 results